What's New AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, including diabetes and coronary artery disease (atherosclerosis). Morgan Stanley Global Healthcare Unplugged Conference Friday, May 2, 2008 11:10 AM EDT